These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22416677)

  • 61. Antifibrinolytic therapy in surgery for congenital heart disease.
    Eaton MP
    Anesth Analg; 2008 Apr; 106(4):1087-100. PubMed ID: 18349177
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effects of aprotinin on blood product transfusion associated with thoracic aortic surgery requiring deep hypothermic circulatory arrest.
    Seigne PW; Shorten GD; Johnson RG; Comunale ME
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):676-81. PubMed ID: 11139108
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aprotinin versus tranexamic acid in children undergoing cardiac surgery: an observational study.
    Willems A; De Groote F; Dumoulin M; Fils JF; Van der Linden P
    Eur J Cardiothorac Surg; 2019 Oct; 56(4):688-695. PubMed ID: 30928999
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low-dose aprotinin in cardiac operations.
    Haddad R; Kesrouani C; Nasr W
    J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological strategies for blood conservation in cardiac surgery: erythropoietin and antifibrinolytics.
    Hardy JF
    Can J Anaesth; 2001 Apr; 48(4 Suppl):S24-31. PubMed ID: 11336434
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The risk associated with aprotinin in cardiac surgery.
    Mangano DT; Tudor IC; Dietzel C; ;
    N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 70. Aprotinin to decrease bleeding and intraoperative blood transfusion requirements during descending thoracic and thoracoabdominal aortic aneurysmectomy using cardiopulmonary bypass.
    Godet G; Bertrand M; Samama CM; Barré E; Fléron MH; Baron JF; Coriat P; Kieffer E; Viars P
    Ann Vasc Surg; 1994 Sep; 8(5):452-6. PubMed ID: 7529038
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thromboelastography--does it impact blood component transfusion in pediatric heart surgery?
    Kane LC; Woodward CS; Husain SA; Frei-Jones MJ
    J Surg Res; 2016 Jan; 200(1):21-7. PubMed ID: 26237992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Use of antifibrinolytics in pediatric cardiac surgery: Where are we now?
    Faraoni D; Rahe C; Cybulski KA
    Paediatr Anaesth; 2019 May; 29(5):435-440. PubMed ID: 30365221
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Use of aprotinin during pediatric heart surgery].
    Martín Burcio S; Valiño González J; Domínguez F; Díaz Balda J; Martínez M; Vellibre D
    Rev Esp Anestesiol Reanim; 2001 May; 48(5):212-6. PubMed ID: 11412731
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Implementation of a transfusion algorithm to reduce blood product utilization in pediatric cardiac surgery.
    Whitney G; Daves S; Hughes A; Watkins S; Woods M; Kreger M; Marincola P; Chocron I; Donahue B
    Paediatr Anaesth; 2013 Jul; 23(7):639-46. PubMed ID: 23506389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial.
    Cholette JM; Powers KS; Alfieris GM; Angona R; Henrichs KF; Masel D; Swartz MF; Daugherty LE; Belmont K; Blumberg N
    Pediatr Crit Care Med; 2013 Feb; 14(2):137-47. PubMed ID: 23287903
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prophylaxis of blood loss and allogenic blood transfusion with fibrinolysis inhibitors produced in Russian Federation in patients undergoing cardiac surgery].
    Bitkova EE; Timerbayev VH; Hvatov VB; Zvereva NY; Chumakov MV; Shumckii KY
    Anesteziol Reanimatol; 2014; (2):59-64. PubMed ID: 25055497
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neonatal cardiopulmonary bypass.
    Pouard P; Bojan M
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2013; 16(1):59-61. PubMed ID: 23561819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only.
    Carrel TP; Schwanda M; Vogt PR; Turina MI
    Ann Thorac Surg; 1998 Jul; 66(1):153-8. PubMed ID: 9692456
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aprotinin reduces operative closure time and blood product use after pediatric bypass.
    Costello JM; Backer CL; de Hoyos A; Binns HJ; Mavroudis C
    Ann Thorac Surg; 2003 Apr; 75(4):1261-6. PubMed ID: 12683573
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of blood products in pediatric cardiac surgery.
    Durandy Y
    Artif Organs; 2015 Jan; 39(1):21-7. PubMed ID: 25626576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.